Particle size of LDL is affected by the National Cholesterol Education Program (NCEP) step II diet in dyslipidaemic adolescents

Shahid Beheshti University of Medical Sciences, Teheran, Tehrān, Iran
British Journal Of Nutrition (Impact Factor: 3.45). 07/2007; 98(1):134-9. DOI: 10.1017/S0007114507657857
Source: PubMed


The objective was to determine the effects of the National Cholesterol Education Program (NCEP) step II diet on LDL and HDL particle size in dyslipidaemic adolescents. Forty-four dyslipidaemic adolescents, aged 10-18 years, participated in this case-control study. The control diet was a diet similar to what most Tehranian adolescents eat. NCEP step II diet was a diet with 30 % of energy as total fat, less than 7 % saturated fat, less than 200 mg cholesterol/d, less than 15 % of energy as MUFA and less than 10 % as PUFA. Lipoprotein particle size was the major outcome variable, which was measured after 3 months of intervention. Comparison was made by the repeated measurement ANOVA. The mean BMI was 26.3 (sd 4.2) kg/m2. There were no significant changes in weight or physical activity in the two groups during the study. The NCEP diet resulted in higher reduction in total cholesterol ( - 13 (sd 4) v. - 2 (sd 0.3) mg/dl, P < 0.001) and LDL ( - 9 (sd 2) v. 3 (sd 0.6) mg/dl, P < 0.01), and higher increase in size of the LDL (1.7 (sd 0.4) v. 0.1 (sd 0.4) nanometer, P < 0.001). HDL particle size did not change significantly. NCEP step II diet had a favourable effect on the LDL particle size. The related mechanism needs to be studied in future experimental designs.

Download full-text


Available from: Parvin Mirmiran
  • Source

    Preview · Article · Jan 2007
  • [Show abstract] [Hide abstract]
    ABSTRACT: Atherosclerosis represents a disease that begins in childhood, and alterations in lipid concentration play a fundamental role in the development of this condition. Children and adolescents with high cholesterol levels are more likely than their peers in the general population to present with dyslipidemia in adulthood. Precocious identification of dyslipidemias associated with premature cardiovascular disease is crucial during childhood to delay or prevent the atherosclerotic process. The National Cholesterol Education Program has established guidelines for the diagnosis and treatment of dyslipidemia during pediatric age. It has been suggested that a heart-healthy diet should begin at 2 years of age, and no adverse effects on psychological aspects, growth, pubertal development and nutritional status in children and adolescents limiting total and saturated fat intake have been demonstrated. Pharmacotherapy should be considered in children aged 10 years or older when low-density lipoprotein cholesterol concentrations remain very high despite dietary therapy, especially when multiple risk factors are present. The lipid-lowering drugs recommended for childhood and adolescence are resins and statins. The increasing use of statins is dependent on their effectiveness and safety. Ezetimibe, a selective cholesterol absorption inhibitor, may provide a similar cholesterol-lowering effect as that reached with statin treatment. This review provides an update on recent advances in the therapy of dyslipidemia, especially hypercholesterolemia, during pediatric age and adolescence.
    No preview · Article · Aug 2008 · Expert Review of Endocrinology &amp Metabolism
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study investigated the relationship between changes in lipoprotein particle size and body weight change over a 9-year period in Japanese adult men and women. Among 299 INTERMAP Toyama Study participants aged 40-59 in 1997, 260 were followed up in 2006 (129 men and 131 women). Their body weight and lipoprotein particle sizes were measured in 1997 and 2006. Nuclear Magnetic Resonance spectroscopy was used for the measurement of lipoprotein particle size. The number of small LDL particles decreased from 774.3 to 617.4 nmol/L in men (p=0.005) while the number increased from 353.2 to 414.5 nmol/L in women (p=0.028) over this period. No significant changes in mean body weight were noted in either sex. Nine-year body weight change was positively associated with changes in the numbers of small LDL particles (men, r=0.37, p<0.001; women, r=0.21, p=0.018), but inversely associated with changes in LDL particle size (men, r=-0.30, p=0.001; women, r=-0.16, p=0.066) and HDL particle size (men, r=-0.42, p<0.001; women, r=-0.42, p<0.001). These relationships were similar even when adjusted for age, baseline body mass index, baseline values for LDL and HDL particle sizes, and other factors. The number of small LDL particles increased in both men and women in the body weight gain group. In the body weight loss group, the number of small LDL particles decreased in men but did not decrease in women. This 9-year observational study showed that the number and size of lipoprotein particles were strongly influenced by long-term body weight change.
    No preview · Article · Feb 2009 · Atherosclerosis
Show more